Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 30 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Narasaraju T.

United States

USD 30 /hr

Infectious diseases scientist with more than 20 years of experience working on respiratory and infectious diseases

Profile Summary

PhD in Microbiology with experience in Infectious Diseases, Influenza, Corona viruses, Bacterial pneumonia, Preclinical models including mice, rats and pigs.

Subject Matter Expertise

• ☆ Infectious Disease
• ☆ Viral Diseases
• ☆ Respiratory Syncytial Virus (RSV)
• ☆ COVID-19
• ☆ Inflammation

Services

• Writing
• Research
• Consulting
• Data & AI
• Product Development

Writing Technical Writing, Newswriting

Research Market Research, User Research, Gap Analysis, Gray Literature Search, Systematic Literature Review

Consulting Scientific and Technical Consulting

Data & AI Statistical Analysis, Big Data Analytics

Product Development Formulation, Product Evaluation, Product Validation

Work Experience

Professor

Adichunchanagiri University, Karnataka, India

January 2022 - Present

Project Leader

Oklahoma State University

July 2013 - December 2020

Education

PhD

Osmania University

January 1995 - January 2001

Certifications

• No

  No

  January 2022 - January 2022

Publications

JOURNAL ARTICLE

(2021). PAD Inhibitors as a Potential Treatment for SARS-CoV-2 Immunothrombosis . Biomedicines.

(2021). Patients with COVID-19: in the dark-NETs of neutrophils . Cell death and differentiation.

(2021). Neutrophils Set Extracellular Traps to Injure Lungs in Coronavirus Disease 2019 . The Journal of infectious diseases.

(2021). Administration of a CXC Chemokine Receptor 2 (CXCR2) Antagonist, SCH527123, Together with Oseltamivir Suppresses NETosis and Protects Mice from Lethal Influenza and Piglets from Swine-Influenza Infection . The American journal of pathology.

(2020). Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19 . Annals of internal medicine.

(2020). Neutrophilia and NETopathy as Key Pathologic Drivers of Progressive Lung Impairment in Patients With COVID-19 . Frontiers in pharmacology.

(2020). SARS-CoV-2 Genomes From Oklahoma, United States . Frontiers in genetics.

(2019). Combination Therapy Targeting Platelet Activation and Virus Replication Protects Mice against Lethal Influenza Pneumonia . American journal of respiratory cell and molecular biology.

(2017). The Role of Extracellular Histones in Influenza Virus Pathogenesis . The American journal of pathology.

(2011). Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis . The American journal of pathology.